Orforglipron Tablets 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, 17.2 mg
Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Manufacturer #22642
Established in 1997, this manufacturer excels as a CTD dossier owner and manufacturer, known for its extensive reach in over 65 countries. It upholds high standards as a GMP manufacturer with advanced production lines and significant expertise in pharmaceuticals, making it a top-tier GMP manufacturer and CTD dossier owner and manufacturer. This commitment ensures compliance with rigorous international standards, maintaining its status as a leading CTD dossier owner and manufacturer.